Home › Immune System and Disorders › Texas › Houston
Immune System and Disorders clinical trials in Houston, TX
9 studies for Immune System and Disorders are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- The University of Texas - MD Anderson Cancer Center, Houston
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RecruitingPhase 2
- Jade Clinical Site, Houston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Baylor College of Medicine, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingPhase 2
- The University of Texas MD Anderson Cancer Center, Houston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RecruitingPhase 3
- Baylor College of Medicine, Houston
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RecruitingPhase 3
- Nephro Asso North Illinois Indiana, Houston
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
RecruitingPhase 2
- Texas Children's Hospital, Houston
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
RecruitingPhase 1/2
- MD Anderson Texas Medical Center, Houston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RecruitingPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
About Immune System and Disorders
Your immune system is made up of cells, tissues, and organs that fight infections and diseases. Learn how it works, and about diseases of the immune system.
More about Immune System and Disorders on MedlinePlus
Immune System and Disorders trials in other cities
- Washington, DC13 studies
- New York City, NY12 studies
- Philadelphia, PA10 studies
- Boston, MA10 studies
- Portland, OR9 studies
- Atlanta, GA9 studies
- Los Angeles, CA8 studies
- Cleveland, OH8 studies
- Chicago, IL8 studies
- Milwaukee, WI6 studies
- Cedar Rapids, IA6 studies
- Seattle, WA6 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)122 studies
- Metastatic Cancer104 studies
- Colorectal Cancer103 studies
- Ovarian Cancer90 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer69 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.